Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01623934

Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
1,034 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study includes 2 phases. During phase 1, pregnant women are followed over the course of pregnancy. The phase 2 is a follow-up of the mother-child dyad at 3, 5 and 10-12 year after delivery. The purpose of this phase 1 is to : * assess the contribution and interactions of adipokines in the development of insulin resistance during pregnancy and gestational diabetes; * assess levels of maternal adipokines as determinants of development and fetal growth; * determine the genetic variations that influence levels of adipokines and glucose regulation during pregnancy and in newborns. The purpose of this phase 2 is to: * identify DNA methylation variations at birth that are predictive of childhood overweight/obesity. * identify maternal characteristics associated with DNA methylation variations predictive of childhood overweight/obesity. * establish whether the loci predictive of childhood overweight/obesity at birth are still differentially methylated at 5 years of age (samples collected at 5 years of age). * identify DNA methylation variations at birth that are predictive of childhood neurodevelopment problems at 3, 5 and 10 years of age.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2025-09-01
Completion
2025-09-01
First posted
2012-06-20
Last updated
2024-10-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01623934. Inclusion in this directory is not an endorsement.